FIGURE 4.
Adverse events in Ivabradine group versus placebo group post‐treatment. (A) cardiaovascular mortality; (B) hospital re‐admission for worsening heart failure; (C) visual disturbances; D: asymptomatic bradycardia
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.